Taurolidine Lock in Long Term Parenteral Nutrition

Taurolidine alone or in combination with citrate have been proposed for locking the catheter to reduce the number of catheter infections. As there is not enough evidence to give recommendations in this regard, the study tested the hipothesis that taurolidine improves the outcome of long term paretneral nutrition.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Home Parenteral Nutrition Central Venous Catheter

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Stanley Dudrick's Memorial Hospital

Skawina, 32-050, Poland

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

home parenteral nutrition for at least months before enrollment
presence of central venous cathter

Exclusion criteria

home nutrition < 12 months
catheter in peripheral vein

Treatment and study plan

2% Taurolidine Lock

Drug

Catheter lock with 2% Taurolidine

1.35% Taurolidine

Drug

Catheter lock with 1.35% Taurolidine + citrate

Primary outcomes

Number of CVC infections

Time frame: 12 months

Number of central venous catheter infections

Sponsors and collaborators

Lead sponsor

Stanley Dudrick's Memorial Hospital

Other

Registry information

Official study title

The Value of Taurolidine Lock in Long Term Parenteral Nutrition

Important dates

Study start: 2012
Primary completion: 2013
Study completion: 2013
First posted: Dec 11, 2013
Registry last updated: Dec 11, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed